Kazumasa Takenaka

Transporter-Mediated Protection against Thiopurine-Induced Hematopoietic Toxicity

Partha Krishnamurthy, Matthias Schwab, Kazumasa Takenaka et al. · Cancer Research · 2008 · 140 citations · Full text

Veterinary Medicine, Molecular Medicine, Pharmacology +16

Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer

Kazumasa Takenaka, Shinya Ishikawa, Yozo Kawano et al. · European Journal of Cancer · 2004 · 104 citations

Medicine, Cancer Biology, Oncology +12

Substrate Overlap between Mrp4 and Abcg2/Bcrp Affects Purine Analogue Drug Cytotoxicity and Tissue Distribution

Kazumasa Takenaka, George L. Scheffer, Masashi Adachi et al. · Cancer Research · 2007 · 100 citations

Medicine, Biochemistry, Pharmacology +14

Matrix Metalloproteinase-2 Status in Stromal Fibroblasts, Not in Tumor Cells, Is a Significant Prognostic Factor in Non–Small-Cell Lung Cancer

Shinya Ishikawa, Kazumasa Takenaka, Kazuhiro Yanagihara et al. · Clinical Cancer Research · 2004 · 92 citations · Full text

Medicine, Cancer Biology, Oncology +12

Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients

E. Ogawa, Kazumasa Takenaka, Kazuhiro Yanagihara et al. · British Journal of Cancer · 2004 · 85 citations · Full text

Medicine, Oncology, Pathology +13